$18.27 -0.59 (%) Depomed Inc - NASDAQ

Jan. 30, 2015 | 04:00 PM

Partner Headlines

  1. Depomed

    IBD | Jan. 16, 2015 | 18:35PM EST
  2. Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares Spike Higher

    Benzinga | Jan. 16, 2015 | 15:36PM EST
  3. Depomed Hits High On Big Pain-Drug Deal With J&J

    IBD | Jan. 16, 2015 | 11:32AM EST
  4. Benzinga's Volume Movers

    Benzinga | Jan. 16, 2015 | 11:09AM EST
  5. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 16, 2015 | 10:34AM EST
  6. Morning Market Gainers

    Benzinga | Jan. 16, 2015 | 09:49AM EST
  7. FXCM, Precision Castparts Plummet Early In Friday's Market

    Benzinga | Jan. 16, 2015 | 09:43AM EST
  8. Depomed Surges 8% Following NUCYNTA Acquisition From Janssen Pharmaceuticals

    Benzinga | Jan. 16, 2015 | 08:58AM EST
  9. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 16, 2015 | 08:11AM EST
  10. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest EPS

    Benzinga | Jan. 16, 2015 | 04:47AM EST
  11. DEPOMED

    IBD | Jan. 15, 2015 | 18:37PM EST
  12. Thursday's After-Hours: Intel, Schlumberger Move Following Earnings

    Benzinga | Jan. 15, 2015 | 17:32PM EST
  13. Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion

    Benzinga | Jan. 15, 2015 | 17:23PM EST
  14. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  15. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

    Benzinga | Sep. 26, 2014 | 04:28AM EST
  16. Shares Of Depomed Moving Higher

    Benzinga | Aug. 19, 2014 | 11:14AM EST
  17. DEPOMED

    IBD | Aug. 6, 2014 | 18:46PM EST
  18. Depomed May Be Setting Up In A New Base

    IBD | May. 6, 2014 | 17:17PM EST
  19. Depomed A 'Turtle' Gaining In Specialty Pharma Race

    IBD | Mar. 25, 2014 | 17:52PM EST
  20. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

    Benzinga | Mar. 17, 2014 | 04:42AM EST
  21. Mid-Day Market Update: Stocks Turn Mostly Lower; VeriFone Shares Fall On Downbeat Guidance

    Benzinga | Dec. 18, 2013 | 12:33PM EST
  22. UPDATE: JMP Securities Reiterates on Depomed Following Acquisition of Migraine Asset

    Benzinga | Dec. 18, 2013 | 09:35AM EST
  23. Depomed Acquires US Rights to CAMBIA Migraine Medicine from Nautilus Neurosciences for $48.7M

    Benzinga | Dec. 17, 2013 | 16:08PM EST
  24. UPDATE: Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5M

    Benzinga | Oct. 21, 2013 | 16:03PM EST
  25. Depomed Announces Acquisition Of Lazanda® (fentanyl) Nasal Spray From Archimedes Pharma Limited

    Benzinga | Jul. 29, 2013 | 16:10PM EST
  26. Depomed Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 5, 2012 | 11:11AM EST
  27. Depomed Appoints Dr. Samuel Saks To Its Board Of Directors

    Benzinga | Oct. 9, 2012 | 10:09AM EST
  28. Breeze 3 data for Serada presented at 2012 North American Menopause Society Annual Meeting

    Benzinga | Oct. 3, 2012 | 02:17AM EST
  29. Depomed Files Suit Against The FDA Seeking Grant Of Orphan Drug Exclusivity For Gralise

    Benzinga | Sep. 25, 2012 | 10:31AM EST
  30. Depomed Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 3, 2012 | 13:26PM EST
  31. Depomed Announces Publication of Phase 3 Data from Gralise® (gabapentin) Clinical Trial

    Benzinga | Jul. 23, 2012 | 02:04AM EST
  32. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness | Jun. 22, 2012 | 06:32AM EST
  33. Depomed Announces Acquisition Of Zipsor From Xanodyne Pharmaceuticals, Inc.

    Benzinga | Jun. 21, 2012 | 10:05AM EST
  34. Depomed Announces Issuance of Formulation Patent Covering Gralise® (gabapentin)

    Benzinga | Jun. 6, 2012 | 02:05AM EST
  35. Earnings Scheduled For May 8

    Benzinga | May. 7, 2012 | 18:31PM EST
  36. A Peek Into The Market Before The Trading Starts

    Benzinga | Mar. 5, 2012 | 00:21AM EST
  37. Benzinga's Top Pre-Market Gainers

    Benzinga | Feb. 6, 2012 | 01:10AM EST
  38. Depomed Announces FDA Approval of Merck's JANUMET XR That Accesses Depomed Patents Licensed to Merck

    Benzinga | Feb. 3, 2012 | 09:15AM EST
  39. Depomed Receives Notice of Paragraph IV Certification Against Patents for Gralise

    Benzinga | Jan. 23, 2012 | 09:30AM EST
  40. Options Players Gravitate Toward Depomed Puts

    SchaeffersResearch | Nov. 2, 2011 | 10:53AM EST
Trading Center